Femtobiomed Inc. — Investor Relations & Filings
Femtobiomed Inc. is a cell engineering company that develops technologies for the cell and gene therapy industry. The company's core offering is the CellShot® platform, a proprietary, non-viral intracellular delivery system. This platform utilizes a patented technology known as 'Partitioned Flow Transfection,' which functions as a three-dimensional nanoinjection system for the direct, cargo-free delivery of biomolecules into individual cells. The technology is designed to support the discovery and development of advanced therapeutics, including anti-cancer treatments, for the healthcare and research sectors. Femtobiomed aims to pioneer non-viral cell engineering to accelerate the creation of novel cell therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여) | 2026-05-06 | Korean | |
| 주권매매거래정지기간변경 (개선기간 부여) | 2026-05-06 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | |
| 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2026-03-30 | Korean |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 41752400 | 기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여) | 2026-05-06 | Korean | ||
| 41752360 | 주권매매거래정지기간변경 (개선기간 부여) | 2026-05-06 | Korean | ||
| 34380647 | 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | ||
| 34380646 | 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | ||
| 33119826 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33085997 | 기타시장안내 (상장폐지 관련) | 2026-03-30 | Korean | ||
| 33085992 | 사업보고서 (2025.12) | 2026-03-30 | Korean | ||
| 33085587 | 주권매매거래정지 (상장폐지사유 발생) | 2026-03-30 | Korean | ||
| 33085585 | 감사보고서제출 | 2026-03-30 | Korean | ||
| 33054006 | 본점소재지변경 | 2026-03-27 | Korean | ||
| 33012274 | 사업보고서제출기한연장신고서 (2025.12) | 2026-03-23 | Korean | ||
| 32982207 | 기타주요경영사항(자율공시) (기타주요경영사항(자율공시)(감사보고서 제출 지연)) | 2026-03-19 | Korean | ||
| 32932519 | 주주총회소집공고 | 2026-03-12 | Korean | ||
| 32838375 | 주주총회소집결의 | 2026-02-26 | Korean | ||
|
2025
1 filing
| |||||
| 33030887 | 주식등의대량보유상황보고서(일반) | 2025-11-06 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Femtobiomed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16340/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16340 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16340 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16340 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16340}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Femtobiomed Inc. (id: 16340)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.